BNP Paribas Financial Markets’s Q32 Bio QTTB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.86K | Hold |
303
| – | – | ﹤0.01% | 5491 |
|
|
2026
Q1 | $1.95K | Sell |
303
-5
| -2% | -$24 | ﹤0.01% | 5424 |
|
|
2025
Q4 | $1.02K | Sell |
308
-124
| -29% | -$350 | ﹤0.01% | 5404 |
|
|
2025
Q3 | $855 | Buy |
432
+29
| +7% | +$56 | ﹤0.01% | 5254 |
|
|
2025
Q2 | $600 | Sell |
403
-182
| -31% | -$310 | ﹤0.01% | 5206 |
|
|
2025
Q1 | $965 | Sell |
585
-319
| -35% | -$859 | ﹤0.01% | 5077 |
|
|
2024
Q4 | $3.11K | Sell |
904
-394
| -30% | -$12.4K | ﹤0.01% | 4971 |
|
|
2024
Q3 | $57.9K | Buy |
1,298
+864
| +199% | +$31.7K | ﹤0.01% | 3590 |
|
|
2024
Q2 | $7.79K | Buy |
+434
| New | +$10.4K | ﹤0.01% | 3745 |
|
|
2023
Q4 | – | Sell |
-12
| Closed | -$249 | – | 4113 |
|
|
2023
Q3 | $249 | Hold |
12
| – | – | ﹤0.01% | 3817 |
|
|
2023
Q2 | $188 | Buy |
+12
| New | +$215 | ﹤0.01% | 3830 |
|
|
2023
Q1 | – | Sell |
-15
| Closed | -$333 | – | 4075 |
|
|
2022
Q4 | $333 | Sell |
15
-5,400
| -100% | -$143K | ﹤0.01% | 3891 |
|
|
2022
Q3 | $157K | Sell |
5,415
-197
| -4% | -$8.03K | ﹤0.01% | 3591 |
|
|
2022
Q2 | $199K | Buy |
5,612
+20
| +0.4% | +$683 | ﹤0.01% | 3088 |
|
|
2022
Q1 | $306K | Sell |
5,592
-956
| -15% | -$59.4K | ﹤0.01% | 2976 |
|
|
2021
Q4 | $429K | Buy |
6,548
+5,992
| +1,078% | +$582K | ﹤0.01% | 3079 |
|
|
2021
Q3 | $78.8K | Buy |
556
+119
| +27% | +$15.2K | ﹤0.01% | 3373 |
|
|
2021
Q2 | $57.2K | Buy |
437
+192
| +78% | +$24K | ﹤0.01% | 3220 |
|
|
2021
Q1 | $41.4K | Sell |
245
-112
| -31% | -$23.6K | ﹤0.01% | 3650 |
|
|
2020
Q4 | $72.6K | Sell |
357
-79
| -18% | -$15.3K | ﹤0.01% | 3374 |
|
|
2020
Q3 | $83.9K | Buy |
436
+262
| +151% | +$58.7K | ﹤0.01% | 3208 |
|
|
2020
Q2 | $47.4K | Sell |
174
-413
| -70% | -$110K | ﹤0.01% | 3052 |
|
|
2020
Q1 | $164K | Buy |
587
+425
| +262% | +$130K | ﹤0.01% | 2958 |
|
|
2019
Q4 | $60.2K | Sell |
162
-41
| -20% | -$11.7K | ﹤0.01% | 3541 |
|
|
2019
Q3 | $66.2K | Buy |
203
+97
| +92% | +$33K | ﹤0.01% | 3341 |
|
|
2019
Q2 | $37.2K | Sell |
106
-92
| -46% | -$36.2K | ﹤0.01% | 3610 |
|
|
2019
Q1 | $99K | Buy |
+198
| New | +$88.5K | ﹤0.01% | 3134 |
|
|
2018
Q4 | – | Sell |
-19
| Closed | -$7.82K | – | 4442 |
|
|
2018
Q3 | $7.82K | Hold |
19
| – | – | ﹤0.01% | 3858 |
|
|
2018
Q2 | $6.98K | Buy |
+19
| New | +$6.8K | ﹤0.01% | 3948 |
|
Other funds holding QTTB
AVLSA
VCM
S
VFT
BNP Paribas Financial Markets's QTTB Position: Q2 2026 in Review
BNP Paribas Financial Markets held its Q32 Bio (QTTB) position steady in Q2 2026 at 303 shares worth $3.86K. The position accounts for ﹤0.01% of the portfolio, ranked #5491.
BNP Paribas Financial Markets first reported a position in QTTB in Q2 2018 and has held it in 29 quarters since. The position peaked at $429K in Q4 2021. 43 funds tracked by Wall St. Rank hold QTTB as of Q2 2026.
- BNP Paribas Financial Markets held 303 shares of Q32 Bio worth $3.86K as of Q2 2026.
- BNP Paribas Financial Markets left its Q32 Bio share count unchanged in Q2 2026.
- Q32 Bio made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5491 holding.
- BNP Paribas Financial Markets first reported a position in Q32 Bio in Q2 2018 and has held it in 29 quarters since.
- BNP Paribas Financial Markets's Q32 Bio position peaked at $429K in Q4 2021.
- 43 funds tracked by Wall St. Rank held Q32 Bio as of Q2 2026.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.